Skip to content
10-K

Annual Report

Cantabio Pharmaceuticals Inc.

0001654954-18-007670

← back to feed
Filed
Jul 16, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Jul 9, 2018 53.86M sh
Operating Cash Flow FY 2018 · Mar 31, 2018 −$623.35K
Operating Cash Flow FY 2018 · Mar 31, 2017 −$973.12K
Cash And Equivalents FY 2018 · Mar 31, 2018 $109.43K
Cash And Equivalents FY 2018 · Mar 31, 2017 $32.28K
Cash And Equivalents FY 2018 · Mar 31, 2016 $52.11K
Stockholders Equity FY 2018 · Mar 31, 2018 −$1.87M
Stockholders Equity FY 2018 · Mar 31, 2017 −$853.92K
Stockholders Equity FY 2018 · Mar 31, 2016 −$369.78K
Current Liabilities FY 2018 · Mar 31, 2018 $1.98M
Current Liabilities FY 2018 · Mar 31, 2017 $887.45K
Total Liabilities FY 2018 · Mar 31, 2018 $1.98M
Total Liabilities FY 2018 · Mar 31, 2017 $887.45K
Current Assets FY 2018 · Mar 31, 2018 $109.43K
Current Assets FY 2018 · Mar 31, 2017 $33.52K
Total Assets FY 2018 · Mar 31, 2018 $109.43K
Total Assets FY 2018 · Mar 31, 2017 $33.52K
Sga Expense FY 2018 · Mar 31, 2018 $977.75K
Sga Expense FY 2018 · Mar 31, 2017 $718.96K
Rd Expense FY 2018 · Mar 31, 2018 $371.04K
Rd Expense FY 2018 · Mar 31, 2017 $350.31K
Net Income FY 2018 · Mar 31, 2018 −$2.01M
Net Income FY 2018 · Mar 31, 2017 −$1.11M